These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21370407)
21. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382 [TBL] [Abstract][Full Text] [Related]
22. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Lastowska M; Cotterill S; Pearson AD; Roberts P; McGuckin A; Lewis I; Bown N Eur J Cancer; 1997 Sep; 33(10):1627-33. PubMed ID: 9389925 [TBL] [Abstract][Full Text] [Related]
23. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999 [TBL] [Abstract][Full Text] [Related]
24. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Cunsolo CL; Bicocchi MP; Petti AR; Tonini GP Br J Cancer; 2000 Nov; 83(10):1295-300. PubMed ID: 11044353 [TBL] [Abstract][Full Text] [Related]
25. PPM1D is a potential target for 17q gain in neuroblastoma. Saito-Ohara F; Imoto I; Inoue J; Hosoi H; Nakagawara A; Sugimoto T; Inazawa J Cancer Res; 2003 Apr; 63(8):1876-83. PubMed ID: 12702577 [TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma. Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884 [TBL] [Abstract][Full Text] [Related]
27. Analysis of genomic alterations in neuroblastoma by multiplex ligation-dependent probe amplification and array comparative genomic hybridization: a comparison of results. Combaret V; Iacono I; Bréjon S; Schleiermacher G; Pierron G; Couturier J; Bergeron C; Blay JY Cancer Genet; 2012 Dec; 205(12):657-64. PubMed ID: 23265803 [TBL] [Abstract][Full Text] [Related]
28. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma]. Laureys GG Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912 [TBL] [Abstract][Full Text] [Related]
30. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute. Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533 [TBL] [Abstract][Full Text] [Related]
31. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Plantaz D; Mohapatra G; Matthay KK; Pellarin M; Seeger RC; Feuerstein BG Am J Pathol; 1997 Jan; 150(1):81-9. PubMed ID: 9006325 [TBL] [Abstract][Full Text] [Related]
37. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695 [TBL] [Abstract][Full Text] [Related]
38. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319 [TBL] [Abstract][Full Text] [Related]